With the exception of prostate adenocarcinoma (PRAD), where PKM2 expression was higher in adjacent normal tissues than in tumor tissues, other cancers exhibited overexpression of PKM2 in tumor tissues (Fig. 1B). This evidence concerns the gene PKM and neoplasm.